significant reductions in maternal morbidity and mortality, and improved pain relief and patient satisfaction. 8 -15 Consensus guidelines published by the American Society of Regional Anesthesia and Pain Medicine (ASRA) and the German Society of Anesthesiology and Intensive Care are available for anesthesiologists considering neuraxial techniques in patients receiving hemostasis-altering medications. 16, 17 However, there is little evidence in the literature regarding the application of neuraxial techniques in patients with common bleeding diatheses. These patients may safely and successfully undergo major surgery under general anesthesia provided that the defect is adequately corrected. 18 -29 The objectives of this review are to examine and summarize the reported perioperative management and assess the frequency of hemorrhagic complications in patients with the most common bleeding diatheses (hemophilia, von Willebrand's disease [vWD] , and idiopathic thrombocytopenic purpura [ITP]) with the aim to assist anesthesiologists considering neuraxial techniques in these populations.
METHODS
A systematic search of the PubMed, MEDLINE, and EMBASE databases was performed using the medical subject heading words "regional anesthesia," "neuraxial blockade," "epidural," "spinal," "subarachnoid," "intrathecal," "lumbar puncture," "paravertebral," "steroid," and "caudal." Search results were then cross-referenced with each of the medical subject heading words "coagulopathy," "hemophilia," "von Willebrand," "thrombocytopenia," "ITP," "Immune," and "Idiopathic." Only studies in which neuraxial techniques were performed on patients with the aforementioned bleeding diatheses were included. Acquired forms of hemophilia were excluded. The references of all relevant publications were examined to capture any additional material suited for the present review. The quality of evidence for each identified article was independently graded by each of the authors (highest to lowest I-V) according to the criteria described by Wright et al. (Appendix) . 30, 31 Where possible, the pre-and posttreatment coagulation variables, platelet counts, treatment administered, needle gauge/type used for the block, difficulties noted with placement, and the source authors' recommendations regarding management of the bleeding diatheses were included in the summary tables. Complications were defined as hemorrhage related to the neuraxial technique procedure with or without subsequent neurologic compromise.
RESULTS
Our search yielded 86 articles of which 30 met our inclusion criteria. The quality of evidence score for the 30 source articles in this review was Level IV (Appendix). Sixteen of the 30 articles cited were case reports. [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] Fourteen of the 30 articles were case series. 48 -61 Tables  1-3 summarize the articles according to bleeding defect and by type of neuraxial technique.
Hemophilia
Among six articles, we identified 107 neuraxial techniques performed on 85 patients with hemophilia, and there were no reports of spinal hematoma when the diagnosis of hemophilia was known before the procedure. 32, 37, 38, 51, 52, 58 Of these 107 neuraxial techniques, there were 53 diagnostic lumbar punctures in the emergency room, 35 spinal anesthetics for lower limb orthopedic surgery, 11 lumbar epidural anesthetics for lower limb orthopedic surgery, 7 lumbar epidural anesthetics for labor, and 1 lumbar epidural anesthetic for abdominal surgery. In the 105 neuraxial techniques in which the coagulopathy was known before the block, factor levels were replaced to normal (Ͼ0.5 IU mL Ϫ1 ) before needle insertion, and no hemorrhagic complications were reported. Two neuraxial techniques were performed in patients with undiagnosed hemophilia prior to needle insertion, 32, 38 one of which resulted in the lone complication identified in this review, a catastrophic spinal hematoma 38 (Table 1) .
The management of hemophilia in the patients reviewed herein was not standardized (Table 1) . However, factor VIII/IX levels were normalized (Ͼ0.5 IU mL Ϫ1 ) in all cases in which the diagnosis of hemophilia was known before needle insertion. Treatment most often included specific factor replacement (plasma derived or recombinant) 37,58 with or without 1-deamino-8-D-arginine vasopressin. 32 Two authors did not specify the type or dosage of factor replacement but reported that factor levels were normal before needle insertion. 51, 52 The authors of three of the six source articles specified that removal of the epidural catheter after lumbar epidural analgesia was attempted or intended to be attempted only when factor levels were normalized (Ͼ0.5 IU mL Ϫ1 ). 32, 37, 51 vWD Among 10 articles, we identified 74 neuraxial techniques performed on 72 patients with vWD ranging from mild to severe (Type I, n ϭ 71; Type IIA, n ϭ 2; Type III, n ϭ 1). 33, 34, 36, 41, 42, 45, 53, 54, 59, 60 There were no complications reported among these 72 patients, all of whom received neuraxial techniques for labor analgesia. Of the 74 neuraxial techniques, 72 were for lumbar epidural analgesia, and 2 were combined spinal epidurals. In 64 of the 74 neuraxial techniques, vWD indices were normal before needle insertion and treatment was not initiated. 36, 42, 53, 54, 60 Treatment before needle insertion was initiated for 10 of the 74 neuraxial techniques. 33, 34, 41, 45, 59 Treatment for vWD was dependent on the severity and subtype of vWD (Table 2 ). In 5 of the 10 source articles, previously abnormal vWD indices spontaneously increased to normal or near normal at term Vol. 109, No. 2, August 2009 before lumbar epidural catheter placement for labor analgesia and no treatment was prescribed. 36, 42, 53, 54, 60 Treatment included DDVAP alone, 45, 59 plasmaderived vWF/FVIII concentrate for Types II and III vWD, 41 or FVIII concentrate alone. 34 
ITP
Among 14 articles, we identified 325 patients with ITP who underwent a total of 326* neuraxial techniques. 35,39,40,43,44,46 -50,55-57,61 . Of 326 neuraxial techniques, 324 were in the obstetric population, 1 thoracic epidural catheter was placed for postoperative analgesia, 46 and 1 spinal anesthetic was for non-obstetric surgery in an obstetric patient. 35 In total, 282 lumbar epidural anesthetics, 41 spinal anesthetics, 2 paravertebral blocks, and 1 thoracic epidural anesthetic were placed in the setting of ITP. There were no complications reported.
The perioperative management of neuraxial techniques in ITP varied considerably among the 14 source articles ( Table 3 ). The diagnosis of ITP was known before the block in all but three instances in which the low platelet count was revealed on review of the complete blood count after lumbar epidural analgesia had been initiated. Interestingly, three articles (i.e., ITP was undiagnosed before neuraxial technique) reported the lowest platelet counts before needle insertion among all 14 source articles: 2 ϫ 10 9 L Ϫ1 , 40 18 ϫ 10 9 L Ϫ1 , 56 and 26 ϫ 10 9 L Ϫ1 . 43 The authors of 10 of the 14 source articles did not seek to treat the thrombocytopenia before needle insertion. When the diagnosis of ITP was established *In the largest case series by Frenk et al., there were 170 patients (135 lumbar epidural catheters, 35 spinal blocks) with ITP, gestational thrombocytopenia, and preeclampsia. The authors did not enumerate each entity. 
Faillace et al. 38 A N ϭ 1 ER 1 FVIII activity Ͻ1% aPTT ϭ 156s
None Numeric values presented as ϫ10 9 L Ϫ1 . Hemophilia severity: Mild ϭ 10 to 50% FVIII activity; Moderate ϭ 2 to 10% FVIII activity; Severe ϭ Ͻ1% FVIII activity. AFI ϭ acquired factor inhibitor; aPTT ϭ acquired thromboplastin time; DDAVP ϭ 1-deamino-8-D-arginine vasopressin; ER ϭ emergency room lumbar puncture; FIX ϭ Factor 9 (Normal ϭ 0.5-1.5 IU mL Ϫ1 ); FVIII ϭ Factor 8 (Normal ϭ 0.5-1.5 IU mL Ϫ1 ); G ϭ needle gauge; GEN ϭ general surgical population; Helixate FS® ϭ recombinant factor 8 concentrate (CSL Behring); LEA ϭ lumbar epidural anesthesia; LP ϭ lumbar puncture; N ϭ number of patients; N/A ϭ data not indicated in reference; NT ϭ neuraxial technique; OB ϭ obstetric; ORTHO ϭ orthopedic; POD ϭ postoperative day; PCC ϭ prothrombin complex concentrate; Plt ϭ platelets.
preprocedure, four of the authors sought to reduce the severity of the thrombocytopenia. A platelet count of Ͻ50 ϫ 10 9 L Ϫ1 generally prompted treatment consisting of corticosteroids, IV immune globulin, or platelet transfusion before block performance. 44, 46, 49, 50 Only one source article made any mention of the platelet count at the time of epidural catheter removal. Frenk et al. 50 described that, whenever possible, catheter removal was attempted only when the platelet count was in excess of 60 ϫ 10 9 L Ϫ1 . Nonetheless, these authors reported that 5 of the 135 catheters studied were still removed (without consequence) when the platelet count was Ͻ50 ϫ 10 9 L Ϫ1 , though the reason for this apparent discrepancy was not explained in the article.
DISCUSSION
Spinal hematoma after neuraxial techniques in modern anesthetic practice is rare. The frequency of spinal hematoma in the large (Ͼ1000 subjects) contemporary studies (1995-present) ranges from 0 to 3.70:10,000 [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] and varies considerably depending on the surgical indication, particularly with respect to the obstetric (0 -0.20:10,000) versus the non-obstetric population (0 -3.7:10,000). It, nonetheless, remains one of the most feared complications, mostly because of its potential for irreversible injury and partly because it may be minimized with close attention to modifiable risk factors, namely thromboprophylaxis, traumatic needle insertion, and known coagulopathies. 74 However, there is a paucity of data in the literature regarding the provision of neuraxial techniques in patients with the most common bleeding diatheses. Among the 507 neuraxial techniques identified from 30 published articles of neuraxial techniques in the setting of hemophilia, vWD, or ITP, there was only one reported complication in which the bleeding diathesis was undiagnosed before needle insertion. There was a single case of spinal hematoma after diagnostic lumbar puncture in an undiagnosed hemophiliac infant resulting in permanent paraplegia. 38 We found no other reports of catastrophic or noncatastrophic hemorrhagic complications in the setting of hemophilia, vWD, or ITP. Nonetheless, the data presented herein must be interpreted with caution.
The source articles included in this review are limited to case reports and case series with relatively few total subjects. In addition, the effects of negative reporting and publication bias cannot be discounted. Accordingly, it must be recognized that the absence of evidence does not imply evidence of absence. That is, just because the literature does not contain sufficient data regarding the frequency of hemorrhagic complications after neuraxial techniques in patients with bleeding diatheses does not mean that hemorrhagic complications do not occur often. Vastly (and prohibitively) larger numbers of patients are required to determine the true incidence of epidural hematoma, as well as support or refute the safety of neuraxial techniques, in patients with hemophilia, vWD, or ITP. Moreover, the gross disproportions between surgical indication (e.g., obstetrics vs orthopedics) and neuraxial technique type (e.g., lumbar epidural vs spinal) undermine the validity of any general management recommendations that can be drawn from the present review for at least two important reasons. First, it has been shown that the prevalence of spinal hematoma after neuraxial techniques is considerably less in the obstetric population. 70 validate the results presented in this review article and generate meaningful management strategies for neuraxial techniques.
Relevant professional societies provide minimal, if any, evidence-based guidelines to assist anesthesiologists considering neuraxial techniques in patients with hemophilia, vWD, or ITP. Drawn from expert opinion, retrospective data and case reports, the widely cited consensus statements published by ASRA and the German Society of Anesthesiology and Intensive Care pertain exclusively to patients undergoing neuraxial techniques in the setting of hemostasis altering medications. Neither ASRA, European Society of Regional Anesthesia, the American Society of Anesthesiologists, the Canadian Anesthesiologists Society, † nor the American College of Obstetrics and Gynecology offers any guidelines for the practice of neuraxial techniques in patients with inherited coagulopathies or ITP. 16, 17, 75, 76 Table 4 summarizes available recommendations from professional societies and government agencies regarding the provision of neuraxial techniques in the setting of hemophilia, vWD, or thrombocytopenia. [77] [78] [79] [80] [81] [82] Importantly, each of these guidelines is based †http://www.cas.ca/members/sign_in/guidelines/practice_of_ anesthesia/default.asp?loadϭobstetrical_regional_analgesia, last accessed June 30, 2008. on expert opinion and/or case series with fewer patients than are presented in this review. 52, [83] [84] [85] [86] [87] An in-depth review of hemophilia, vWD, and ITP is not provided as the implications for anesthesia in general have been presented elsewhere. 88 In brief, hemophilia is an inherited bleeding disorder resulting from deficiencies in specific coagulation factors and is diagnosed by direct factor assay. Hemophilia A (80% of hemophiliacs) occurs when there is a deficiency in Factor VIII, and B (20% of hemophiliacs) occurs when Factor IX is deficient. The prevalence of hemophilia A is approximately 1 in 5000, whereas that of hemophilia B is approximately 1 in 25,000. 89 Traditional surgical recommendations for hemophiliacs suggest that major surgery can be safely performed when Factor VIII/IX levels are normalized (Ͼ0.5 IU mL Ϫ1 ). 90 -92 vWD is the most common inherited coagulopathy and is estimated to affect approximately 1%-2% of the general population. It results from either a quantitative or qualitative defect of von Willebrand Factor and is classified into four major subtypes. [93] [94] [95] Laboratory values helpful in diagnosing or assessing the severity of vWD are Factor VIII levels, von Willebrand Factor levels, and Ristocetin Co-factor Activity that assesses von Willebrand Factor binding to platelet glycoproteins. Normal values for each of these laboratory assays are 0.5-1.5 IU mL Ϫ1 . 96, 97 Treatment in the perioperative period ranges from 1-deamino-8-Darginine vasopressin for mild Type I disease, but can progress to cryoprecipitate and high concentration factor replacement as necessary. Specific treatment strategies may be determined in consultation with a hematologist. 90 ITP is characterized by thrombocytopenia without identifiable cause. Its estimated incidence ranges from 1.6 to 6.6 in 100,000 adults per year. 98, 99 Diagnosis is made by history, physical, complete blood count, and peripheral blood smear that have excluded all other etiologies of thrombocytopenia. 98 It is important to note that the platelets that do circulate, and thus are reflected in the platelet count, are fully functional. First-line therapy for ITP, should it be necessary, is the administration of corticosteroids. Second-line therapies include chemotherapeutic drugs, such as azathioprine and vinca alkaloids. For urgent or emergent surgery, transfusion of single donor platelets or IV immune globulin can be most effective. Unfortunate refractory cases of ITP usually undergo splenectomy which offers a 50% chance of cure. 88 The minimum acceptable platelet count that is widely cited for most surgical procedures is 50 ϫ 10 9 L Ϫ1 to maintain adequate primary hemostasis. 78, 82, 100, 101 However, the minimum platelet count at which the risk of hemorrhagic complications from neuraxial techniques becomes prohibitively high remains undefined.
It is noteworthy that lumbar puncture is frequently performed for diagnostic or therapeutic purposes in severely thrombocytopenic patients. Our literature search identified 5445 patients among eight published reports describing the use of neuraxial techniques in the setting of nonimmunologic thrombocytopenia (oncologic primary, chemotherapy, or radiation induced) ( Table 5 ). 86, [102] [103] [104] [105] [106] [107] [108] These patients did not meet our inclusion criteria and are arguably at higher risk for spinal hematoma because lumbar punctures are often performed by individuals with less experience, using larger gauge needles, in more severely thrombocytopenic patients, particularly in cases of leukemia, than neuraxial techniques performed by anesthesiologists. Eight cases of spinal hematomas were reported in patients with platelet counts ranging from 8 to 250 ϫ 10 9 L Ϫ1 and 2 needle insertions described as traumatic. [102] [103] [104] 108 It seems plausible that, given identically low platelet counts, neuraxial techniques in the setting of leukemic thrombocytopenia may be more dangerous than in ITP in pregnancy, but this is wholly speculative.
In summary, there is a paucity of published data regarding the provision and safety of neuraxial techniques in patients with common bleeding diatheses. Based on reports of only 507 neuraxial techniques, of which 406 were in the obstetric population, hemorrhagic complications after neuraxial techniques in patients with known hemophilia, vWD, or ITP appear infrequent when factor levels are more than 0.5 IU mL Ϫ1 for Factor VIII levels, von Willebrand Factor levels, and Ristocetin Co-factor Activity levels, or when the platelet count is more than 50 ϫ 10 9 L Ϫ1 before block performance. The minimum "safe" factor levels and platelet count for neuraxial blockade remain undefined in both the obstetric and general populations and evidence-based recommendations for neuraxial techniques in the setting of hemophilia, vWD, or ITP cannot be offered.
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